Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections | Zendy

Filip Jansåker | Zendy; Niels FrimodtMøller | Zendy; Iwar Sjögren | Zendy; Jenny Dahl Knudsen | Zendy

Open Access

Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

Author(s) -

Filip Jansåker,

Niels FrimodtMøller,

Iwar Sjögren,

Jenny Dahl Knudsen

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt404

Subject(s) - klebsiella pneumoniae , enterobacteriaceae , microbiology and biotechnology , urinary system , medicine , klebsiella , antibiotics , escherichia coli , biology , biochemistry , gene

The prevalence of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing and the therapeutic options are limited, especially in primary care. Recent indications have suggested pivmecillinam to be a suitable option. Here, we evaluated the clinical and bacteriological effects of pivmecillinam in UTIs caused by ESBL-producing Enterobacteriaceae.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research